https://www.selleckchem.com/pr....oducts/bgj398-nvp-bg
Both groups used the same device and were unaware of which group they were in. After a period totaling 18 weeks, patients underwent the final evaluation, as initially performed. Twenty-five patients in total participated until the end of the study (median age 42 years). There were no significant differences between TG and SG based on age, ****, body mass index or severity of genotype. At the end of the training, both groups showed a significant increase in PEmax and PImax, improvement in Vcap and in exercise tolerance and dyspn